Branicks Group is pushing ahead with a far-reaching overhaul, but the next decisive step now lies with its creditors rather ...
Diginex holders backed the Resulticks acquisition package, yet Nasdaq clearance and lender consent are still needed before ...
BioNTech's BNT113 cancer trial missed its first primary endpoint, and CEO Ĺžahin's share sales add to investor unease.
Palantir’s shares came under pressure on Wednesday as hotter-than-expected US inflation data pushed Treasury yields higher ...
Commerzbank monitors sequential regulatory steps on UniCredit's takeover bid into 2027, alongside its ongoing buyback and ...
Micron fell in a broad memory sector sell-off despite fiscal 2026 revenue of $133.19 billion and first-quarter sales guidance ...
Nvidia shares fell 2.7% as higher Treasury yields hit tech stocks, while investors question returns on AI outlays amid rising ...
Rocket Lab pushed Neutron's first launch to 2027 after carbon-fiber dome flaws; shares fell 7.5% Wednesday and 8.0% premarket Thursday.
Plug Power fell 7.4% to EUR 1.30 as Morgan Stanley and Susquehanna lowered price targets, citing slower hydrogen adoption.
Nel ASA Faces a Bigger Test Than New Orders: Q3 Numbers Will Show Whether Losses Are Still Worsening
Analysts expect Nel ASA's Q3 2026 revenue to slide 33.35% to 202.2 million NOK, with loss per share widening to 0.063 NOK amid new order wins.
Ocugen is trying to build an international business before its lead therapy has even cleared the clinic. That is a difficult order in biotech, and the market is ...
Sivers Semiconductors shares fell 17% in a week amid chip market headwinds, rising short interest, and a full share sale by its former chairman.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results